ASX Healthcare Stocks Getting a Boost with FDA News
Telix Pharmaceuticals Limited (ASX: TLX)
Telix Pharmaceuticals Limited is among the best long term healthcare stocks having received a significant boost in its efforts to enhance brain cancer diagnosis with the FDA's acceptance of the New Drug Application for TLX101-CDx, branded as Pixclara?. This innovative imaging agent, designed for PET scans, targets gliomas—common brain tumors that are often difficult to assess using conventional MRI techniques. The FDA has granted Pixclara priority review, setting a target date for decision by April 26, 2025, which positions the product for a potential U.S. launch next year. As there are currently no FDA-approved targeted amino acid PET agents for brain cancer imaging in the U.S., Pixclara aims to fill this critical gap.?
Read More - https://veye.com.au/editorial